Skip to main content
Edwards Lifesciences Logo

1-Year Results from the PASTE Registry

MICLASP study PASCAL - TR

PASTE (PASCAL for Tricuspid Regurgitation – a European registry)

The objective of this largest registry on T-TEER, is to investigate the safety and effectiveness of the PASCAL transcatheter valve repair system in treating severe tricuspid regurgitation in a real-world patient population.¹

lightbulb red icon

The PASTE registry further confirmed that the PASCAL system is a safe and effective option for treating severe TR in all-comers high-risk patient population

Tricuspid Regurgitation (TR) severity reduction

83%

of patients sustained TR≤2+ at 1 year with the PASCAL system1

Graph shows unpaired analysis. Median follow-up duration 363 (IQR 197-412) days
Tricuspid Regurgitation (TR) severity reduction

New York Heart Association (NYHA) functional class

66%

of patients had achieved NYHA Class I/II at 1-year with the PASCAL system1

Median follow-up duration 346 (IQR 189-396) days
New York Heart Association (NYHA) functional class

Download the clinical data insert and learn more about PASCAL Precision system:

1-year-results-from-the-PASTE-Registry

1 year results from the PASTE Registry

Transcatheter Valve Repair for Tricuspid Regurgitation 1-Year results from the PASTE Registry

Download

CIED, cardiac implantable electronic devices; HFH, heart failure hospitalization; IQR, interquartile range; NYHA, New York Heart Association; PH: pulmonary hypertension; T-TEER, tricuspid transcatheter edge-to-edge repair; TR, tricuspid regurgitation.

Get Edwards updates

Be the first to hear about the latest Edwards news, evidence and future events by joining our mailing list today.
Subscribe

References

  1. Wild M.G. et al., Transcatheter Valve Repair for Tricuspid Regurgitation: 1-Year Results from a Large European Real World Registry. J Am Coll Cardiol. 2024 Oct 24:S0735-1097(24)09955-8.
Medical device for professional use

Medical device for professional use

For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).

Edwards, Edwards Lifesciences, the stylized E logo, CLASP, CLASP II, the CLASP logo, PASCAL, PASCAL Ace, and PASCAL Precision are trademarks or services marks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners.

PP--EU-6699 v2.0

Edwards Lifesciences Sàrl  •  Route de I’Etraz 70, 1260 Nyon, Switzerland | Edwards.com